RIFAM+ISONIAZID 150MG/75MG TABLET (FIXCOM 2) 80S

₱918.00

Rifampicin + Isoniazid (Fixcom 2) is an essential fixed-dose combination tablet for the effective treatment of pulmonary and extrapulmonary tuberculosis. Designed for the continuation phase of therapy, it combines two powerful antibiotics to ensure the complete eradication of bacteria and prevent drug resistance. Available in a box of 80 film-coated tablets for reliable daily maintenance.

 

Note: This is a prescription-only medication (RX). It should be taken on an empty stomach (1 hour before or 2 hours after meals). It may cause a harmless reddish-orange discoloration of urine, tears, and other body fluids. Always consult your doctor for proper dosage based on body weight

SKU: GP1289 Category:

Here is the optimized content for the Rifampicin + Isoniazid (Fixcom 2) 150mg/75mg Tablet (Box of 80s) for your website:

Rifampicin + Isoniazid (Fixcom 2) is a potent fixed-dose combination (FDC) therapy specifically designed for the continuation phase of short-course chemotherapy for Tuberculosis (TB). Indicated for both pulmonary and extrapulmonary tuberculosis, this dual-action medication simplifies treatment by combining two of the most powerful bactericidal agents into a single film-coated tablet.

 

This formulation works through the synergistic action of its active ingredients:

  • Rifampicin (150mg): A powerful antibiotic that inhibits bacterial RNA synthesis, effectively killing actively dividing and semi-dormant Mycobacterium tuberculosis bacilli. It is considered the most potent sterilizing drug available.

     

  • Isoniazid (75mg): A primary antituberculosis drug that interferes with the cell wall synthesis of the bacteria. It is highly bactericidal against rapidly growing bacilli.

     

By using the Fixcom 2 combination, patients benefit from a reduced pill burden, which significantly improves treatment compliance and helps prevent the development of multi-drug resistant TB (MDR-TB). This product is manufactured by Lloyd Laboratories, Inc. for Natrapharm, Inc., ensuring high-quality standards for respiratory health in the Philippines.

 

Key Benefits:

  • Optimized Continuation Phase Therapy: Specifically formulated for the 4-month continuation phase of TB treatment.

     

  • Synergistic Bactericidal Action: Dual-action formula ensures the thorough eradication of TB bacilli.

  • Improved Compliance: The fixed-dose combination reduces the number of tablets needed daily, making it easier to complete the full course of treatment.

     

  • Simplifies Medication Regimen: Prevents the confusion of taking multiple separate drugs, ensuring the correct ratio of Rifampicin and Isoniazid is consumed.

     

  • Value Box (80s): Convenient packaging to support a consistent and uninterrupted treatment schedule.

Shopping Cart
Scroll to Top